Hm Payson & CO Novo Nordisk A S Transaction History

Hm Payson & CO

$5.6 Billion
Q1 2025

A detailed history of Hm Payson & CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Hm Payson & CO holds 7,041 shares of NVO stock, worth $558,562. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,041

Previous 4,441 58.55%

Holding current value

$558,562

Previous $382,000 27.75%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 29, 2025	BUY	$69.3 - $90.95 $180,180 - $236,470	2,600 Added 58.55%	7,041 $488,000
Q4 2024 Feb 07, 2025	BUY	$85.0 - $120.04 $26,860 - $37,932	316 Added 7.66%	4,441 $382,000
Q3 2024 Oct 28, 2024	BUY	$119.07 - $145.42 $17,860 - $21,812	150 Added 3.77%	4,125 $491,000
Q2 2024 Aug 13, 2024	BUY	$122.71 - $146.91 $12,884 - $15,425	105 Added 2.71%	3,975 $567,000
Q1 2024 Jun 20, 2024	SELL	$102.11 - $135.92 $5,718 - $7,611	-56 Reduced 1.43%	3,870 $496,000
Q3 2023 Nov 06, 2023	BUY	$90.94 - $199.54 $178,515 - $391,697	1,963 Added 100.0%	3,926 $357,000
Q2 2023 Jul 17, 2023	SELL	$155.98 - $172.65 $2,183 - $2,417	-14 Reduced 0.71%	1,963 $317,000
Q1 2023 Apr 18, 2023	BUY	$132.34 - $159.14 $1,852 - $2,227	14 Added 0.71%	1,977 $314,000
Q4 2022 Feb 06, 2023	BUY	$102.55 - $135.33 $2,871 - $3,789	28 Added 1.45%	1,963 $265,000
Q3 2022 Oct 25, 2022	SELL	$95.28 - $116.93 $190 - $233	-2 Reduced 0.1%	1,935 $193,000
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $206 - $243	2 Added 0.1%	1,937 $215,000
Q4 2021 Feb 15, 2022	SELL	$95.88 - $117.08 $3,643 - $4,449	-38 Reduced 1.93%	1,935 $217,000
Q2 2021 Aug 17, 2021	BUY	$67.66 - $84.76 $13,870 - $17,375	205 Added 11.6%	1,973 $165,000
Q1 2021 Jun 15, 2021	SELL	$67.06 - $75.82 $19,313 - $21,836	-288 Reduced 14.01%	1,768 $119,000
Q4 2020 Mar 10, 2021	BUY	$63.89 - $73.8 $105,801 - $122,212	1,656 Added 414.0%	2,056 $144,000
Q3 2020 Dec 21, 2020	SELL	$63.69 - $70.22 $127,380 - $140,440	-2,000 Reduced 83.33%	400 $28,000
Q2 2020 Aug 13, 2020	SELL	$58.54 - $67.94 $32,197 - $37,367	-550 Reduced 18.64%	2,400 $157,000
Q1 2020 Jul 01, 2020	BUY	$49.46 - $64.78 $9,892 - $12,956	200 Added 7.27%	2,950 $178,000
Q2 2019 Aug 15, 2019	BUY	$46.79 - $52.47 $128,672 - $144,292	2,750 New	2,750 $140,000

Others Institutions Holding NVO

# of Institutions

1,769

Shares Held

330M

Call Options Held

11.3M

Put Options Held

15.5M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $179B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.

Account